Frequently Asked Questions

The primary criterion for automatic transfer was current IRB approval. Any study that held a valid, unexpired IRB approval at the time of the transition was considered active and was migrated into myUABResearch. This approach ensured that ongoing research could continue without interruption and that study teams would not need to resubmit studies that were already approved and in progress.

Note that exempt studies more than one year old were not migrated into MURE. These protocols meet the criteria that means they are not subject to (exempt from) the human subjects regulations in the way that expedited and convened studies are. This is why there is not a continuing review requirement. Any change to one of the exempt projects is an entirely new determination, not a continuation of approval b/c it was never an approval. Because exempt determinations do not carry an expiration date or require continuing review, they were managed differently during the transition. These studies remain valid under their existing determinations and documentation in IRAP, and study teams only need to enter them into myUABResearch if a modification requiring a protocol is needed, as described below.

Archived or inactive protocols cannot be transferred into myUABResearch. Their documentation remains accessible in the IRAP archive, including prior submissions, approval correspondence, and other records needed for publications, audits, or study-history questions.

Study teams must maintain complete regulatory documentation and study records in hard-copy or electronic regulatory binders, regardless of transfer status. The IRAP archive supports retrieval but does not replace this responsibility. Studies closed before the transition remain subject to applicable record-retention policies.

For publications or audits, teams may reference IRAP documentation and their regulatory binders. Archived records do not establish that a protocol can be amended or that research may resume under its previous status.

Before changing an archived or inactive study, consult HRPP about the appropriate submission pathway and whether a new submission is required. Access to historical records does not replace required review and approval for future research.

Only exempt protocols more than one year old may require a bridge submission into myUABResearch (MURE). All other studies with current IRB approval were migrated automatically. These exempt studies remain valid under their existing determinations, so a MURE submission is not required simply because the system changed. The study team only needs to enter the study into MURE and submit a modification when a change is needed.

Teams with exempt studies older than one year do not need to start from scratch. The Office of Research developed an AI tool that maps existing IRAP e-portfolio information into the new MURE protocol template, reducing manual re-entry. Because the e-portfolio may not contain every element the new template requires, teams must review the draft and complete or update those sections before submitting. Problems with the tool should be reported through an ASK IT ticket.

To request PI proxy access, log a ticket requesting this access. This functionality...

• adds PI proxies to existing IRB submissions overnight, and
• automatically adds PI proxies to new IRB submissions.

• Role based user dashboards which provide ease of use and transparency.
• Enhanced reporting capabilities at the project, department, and school level.
• Smart form technology which provides electronic submission to research offices.
• Direct System-to-System (S2S) submission to grants.gov agencies such as NIH and CDC.
• Automated system alerts informing researchers when important due dates are approaching.

Phase 1:

Grants (S2S), Agreements and Conflict of Interest

Phase 2:

IRB and Export Control

Phase 3:

IACUC and Vivarium Operations

• Emory University
• Icahn School of Medicine at Mount Sinai
• New York University
• Ohio State University
• University of California
• University of Florida
• University of Minnesota
• University of Pittsburgh
• University of Texas Southwestern Medical Center
• University of Washington
• University of Wisconsin - Madison
• Vanderbilt University

• Auburn University
• Boston University
• Carnegie Mellon University
• Case Western Reserve University
• Children's Hospital of Philadelphia/li>
• Florida State University
• Johns Hopkins University
• Lawrence Berkeley National Laboratory
• Memorial Sloan Kettering Cancer Center
• Michigan State University
• National Aeronautics and Space Administration (NASA)
• National Institutes of Health (NIH)
• Northwestern University
• Penn State University
• Princeton University
• RAND Corporation
• Rockefeller University
• Rutgers University
• Sanford Health
• Texas A&M University
• University of Chicago
• University of Cincinnati
• University of Georgia
• University of Houston
• University of Kansas
• University of Maryland, Baltimore School of Medicine
• University of Miami
• University of New Mexico
• University of Southern California - CHLA
• University of Tennessee
• University of Texas - Austin
• University of Texas Health Science Center San Antonio
• University of Utah
• University of Vermont
• Wake Forest University